Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Remimazolam Sedation on Outcomes of Mechanically Ventilated Patients in the ICU
NCT07596589Phase 3Recruiting
- Sponsor
- Southeast University
- Start
- Apr 2025
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of remimazolam in agitation, anxiety disorder, sponsored by Southeast University. Started Apr 2025; status: recruiting.
02
Drugs
remimazolam
03
Conditions
agitationanxiety disorder
Beyond the preview
Go deeper on NCT07596589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07596589.